๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Type 2 Diabetes Mellitus in Obese

A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D NCT07702890Phase 1, Phase 21 site๐Ÿ“ Neuss Gubra A/S ยท Tests: GUB-UCN2, Placebo A Clinical Study on Using Multimodal Ultrasound to Assess Muscle Mass in Metabolic Diseases NCT07836088n/a1 site๐Ÿ“ Zhangzhou Zhangzhou Municipal Hospital Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention. NCT07415720NA1 site๐Ÿ“ Pamplona Clinica Universidad de Navarra, Universidad de Navarra ยท Tests: Artichoke by-product capsules, Energy-restricted Mediterranean diet (erMeDiet), Placebo capsules, Physical activity Lean Beef as Part of a Healthy Meal Plan in Adolescents With Polycystic Ovary Syndrome (PCOS)/Polyendocrine Metabolic Ovarian Syndrome (PMOS) NCT07780188NA1 site๐Ÿ“ College Station Texas A&M University ยท Tests: Beef+ Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction NCT06953180n/a1 site๐Ÿ“ Almaty Asfendiyarov Kazakh National Medical University ยท Tests: Genetic: DNA analysis Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults NCT07513168Phase 41 site๐Ÿ“ Hyderฤbฤd Asian Institute Of Medical Sciences ยท Tests: Locally available low-dose semaglutide (0.25 mg, 0.5 mg, 1 mg) Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes NCT07835360n/a2 sites๐Ÿ“ Mexico City๐Ÿ“ Mexico City Instituto Nacional de Ciencias Medicas y Nutricion Salvadorโ€ฆ Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study NCT07447362NA1 site๐Ÿ“ Santiago Universidad Catรณlica San Antonio de Murcia ยท Tests: Structured Cardiovascular Risk Management Effect of Sleep Extension on Ceramides in People With Overweight and Obesity NCT06180837NA1 site๐Ÿ“ Salt Lake City University of Utah ยท Tests: Sleep Extension Intervention Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes NCT07478263NA1 site๐Ÿ“ La Jolla University of California, San Diego ยท Tests: Regulation of Cues A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment NCT07807059Phase 11 site๐Ÿ“ Chengdu Fujian Shengdi Pharmaceutical Co., Ltd. ยท Tests: HRS-4729 Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity NCT06782139Phase 41 site๐Ÿ“ Seoul Korea University Anam Hospital ยท Tests: Enavogliflozin, Placebo Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM) NCT06562907Phase 13 sites๐Ÿ“ Miami๐Ÿ“ San Antonio๐Ÿ“ Salt Lake City Gilead Sciences ยท Tests: GS-4571, Placebo, Omeprazole Culturally Adapted Dietary Clinical Trial in PR NCT05962372NA1 site๐Ÿ“ San Juan Harvard School of Public Health (HSPH) ยท Tests: Culturally tailored food and diet advice, Standard healthy eating advice Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes NCT07098663Phase 21 site๐Ÿ“ Bayswater Mankind Pharma Limited ยท Tests: MKP10241, Placebo A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes NCT07670416Phase 321 sites๐Ÿ“ Zhengzhou๐Ÿ“ Xianyang๐Ÿ“ Ningbo Hoffmann-La Roche ยท Tests: Enicepatide, Placebo Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus NCT07282743Phase 221 sites๐Ÿ“ Little Rock๐Ÿ“ Hialeah Gardens๐Ÿ“ Lakeland Sun Pharmaceutical Industries Limited ยท Tests: GL0034 Dose Level 1, GL0034 Dose Level 2, GL0034 Dose Level 3, GL0034 Dose Level 4, GL0034 Dose Level 5 A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity NCT07747857Phase 112 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Langfang Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ยท Tests: TQF3250 capsules, TQF3250 placebo Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population NCT05799222n/a1 site๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: Bariatrix Meal Replacement Products SnapDandCGMinType2DM NCT07533604NA1 site๐Ÿ“ Bangkok Ramathibodi Hospital ยท Tests: SnapD, Linx CGM, Diabetes Self-Management Education (DSMES) A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event NCT07783802Phase 246 sites๐Ÿ“ Huntsville๐Ÿ“ Tucson๐Ÿ“ Tucson Eli Lilly and Company ยท Tests: Clazakizumab, Placebo Pancreas Lipotoxicity in T2D: Edinburgh Diabetes Remission Study (EDRS) NCT07364045NA1 site๐Ÿ“ Edinburgh University of Edinburgh ยท Tests: Total Diet Replacement (TDR) Program AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight NCT07533175Phase 374 sites๐Ÿ“ Birmingham๐Ÿ“ Escondido๐Ÿ“ Lomita Novo Nordisk A/S ยท Tests: NNC0487-0111, Placebo (matched to NNC0487-0111) Adaptive Mechanisms In GRown up ObeSity Study (AMIGROS) NCT06065930n/a1 site๐Ÿ“ Gothenburg Vastra Gotaland Region ยท Tests: Subcutaneous microdialysis Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis NCT07401992Phase 41 site๐Ÿ“ Monterrey Hospital Universitario Dr. Jose E. Gonzalez ยท Tests: Semaglutide (Rybelsusยฎ), Placebo Investigating the Link Between Advanced Glycation End Products (AGEs) and Muscle Wasting in Sarcobesity NCT06438900n/a1 site๐Ÿ“ Novara Azienda Ospedaliero Universitaria Maggiore della Carita A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication NCT07868354Phase 12 sites๐Ÿ“ Glendale๐Ÿ“ Baltimore Novo Nordisk A/S ยท Tests: Tirzepatide, Zenagamtide Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention NCT03875625NA1 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: Bariatric surgery, Dietitian led life style modification intervention, Conventional care (control) Effects of HIIT vs. TRE on Type 2 Diabetes Risk NCT07215533NA1 site๐Ÿ“ Syracuse Syracuse University ยท Tests: High-intensity interval training, Time-restricted eating A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants and in Participants With Cardiovascular Risk Factors NCT07463196Phase 11 site๐Ÿ“ Groningen AC Immune SA ยท Tests: Placebo, ACI-19764 at dose A1, ACI-19764 at dose A2, ACI-19764 at dose A3, ACI-19764 at dose A4
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy